Table 2.
Summary of patient characteristics
| Patient characteristic | No. (%) of randomized clinical trials (N = 157) |
|---|---|
| Age, mean, years | |
| 65.0–67.9 | 38 (24.2) |
| 68.0–74.9 | 69 (43.9) |
| 75.0–85.0 | 36 (22.9) |
| Age, median, years | |
| 65.4–83.0 | 7 (4.5) |
| Age, range, years | |
| 60.0–94.0a | 1 (0.6) |
| 65.0–79.0 | 1 (0.6) |
| Not reported | 5 (3.2) |
| % Women | |
| 0–49.9 | 47 (29.9) |
| 50–100 | 49 (31.2) |
| Not reported | 61 (38.9) |
| Chronic diseasesb | |
| Cardiovascular | 63 (40.1) |
| Respiratory | 23 (14.6) |
| Multimorbidity | 21 (13.4) |
| Neurological | 20 (12.7) |
| Diabetes | 15 (9.6) |
| Mental illness | 6 (3.8) |
| Musculoskeletal disorders | 4 (2.5) |
| Hypertension | 3 (1.9) |
| Frailty | 1 (0.6) |
| Chronic kidney disease | 1 (0.6) |
| Co-morbidities reportedc | |
| Yes | 93 (59.2) |
| No | 52 (33.1) |
| Unclear/not reported | 12 (7.6) |
| Comorbidity score reported | |
| No | 111 (70.7) |
| Yes | 46 (29.3) |
aStudy reports on stratified age groups (60–74, 75 years). We included only the 75 age data in this paper
bThe primary condition that is being treated/managed in the trial (e.g. hypertension)
cComorbidities are additional diseases already existing or which occurred during the study that the individuals have along with a primary chronic disease[202, 203]